Have a personal or library account? Click to login
A case report: clinically benign anti-Csa Cover

A case report: clinically benign anti-Csa

By: T. Sererat,  J. Alexander and  J. Beatty  
Paid access
|Dec 2020

References

  1. Giles CM, Huth MC, Wilson TE, Lewis HBM, Grove GEB. Three examples of a new antibody, anti-Csa, which reacts with 98% of red cell samples. Vox Sang 1965;10:405–15.10.1111/j.1423-0410.1965.tb04354.x
  2. Shore GM, Steane EA. Survival of incompatible red cells in a patient with anti-Csa and three other patients with antibodies to high-frequency red cell antigens (abstract). Transfusion 1978;18:387.
  3. Valko DA, Silberstein ED, Greenwalt TJ, Issitt PD. Normal survival of in-vitro reactive red cells in one patient with anti-McCa and one with anti-Csa (abstract). Transfusion 1981;21:603.
  4. Molthan L, Wick RW Jr, Gross GM. Extravascular hemolytic transfusion reactions due to anti-Yka + Csa. Rev Franc Transfus Inmunohematol 1981;24:263–71.10.1016/S0338-4535(81)80205-X
  5. Widmann FK, ed. Technical Manual. 9th ed. Arlington: VA American Association of Blood Banks, 1985.
  6. Hunt JS, Beck MS, Harman MA, Tegtmeier GE, Bayer WL. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 1980;74:259–64.10.1093/ajcp/74.3.2597416078
DOI: https://doi.org/10.21307/immunohematology-2019-1044 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 71 - 72
Published on: Dec 20, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 T. Sererat, J. Alexander, J. Beatty, published by American National Red Cross
This work is licensed under the Creative Commons License.